Addressing multilevel barriers to clinical trial participation among Black and White men with prostate cancer through the PACCT study.

Findings suggest the greatest enrollment barrier is eligibility for an available trial, but a communication intervention can improve communication quality and trial invitation rates, especially for eligible Black patients.